Page last updated: 2024-08-24

atorvastatin and Myositis, Multiple

atorvastatin has been researched along with Myositis, Multiple in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flores, RM; Kanth, R; Shah, MS1
Niklas, A; Niklas, K; Puszczewicz, M; Tykarski, A; Wolska-Bułach, A1
Albert, A; Bourré-Tessier, J; Drouin, J; Ferreira, J; Fritzler, MJ; Goulet, JR; Goulet, M; Landon-Cardinal, O; Rich, E; Robitaille, Y; Senécal, JL; Targoff, IN; Troyanov, Y1
Famularo, G; Gasbarrone, L; Minisola, G1

Other Studies

4 other study(ies) available for atorvastatin and Myositis, Multiple

ArticleYear
Statin-associated polymyositis following omeprazole treatment.
    Clinical medicine & research, 2013, Volume: 11, Issue:2

    Topics: Anticholesteremic Agents; Atorvastatin; Drug Interactions; Esophagitis; Gemfibrozil; Heptanoic Acids; Humans; Male; Methotrexate; Middle Aged; Myocardial Infarction; Omeprazole; Polymyositis; Prednisone; Proton Pump Inhibitors; Pyrroles; Treatment Outcome; Withholding Treatment

2013
Polymyositis induced by atorvastatin.
    Kardiologia polska, 2015, Volume: 73, Issue:12

    Topics: Atorvastatin; Female; Glucocorticoids; Humans; Middle Aged; Polymyositis; Prednisone

2015
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
    Medicine, 2017, Volume: 96, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Autoantibodies; Autoimmune Diseases; Complement Membrane Attack Complex; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induction Chemotherapy; Longitudinal Studies; Male; Methylprednisolone; Middle Aged; Muscle, Skeletal; Polymyositis

2017
Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link?
    Expert opinion on drug safety, 2010, Volume: 9, Issue:6

    Topics: Atorvastatin; Autoimmune Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Polymyositis; Pyrroles

2010